Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
SeeWhyDY's Profile
Displaying 1-50 of 387 result(s).
CYDY CytoDyn Inc
07/22/2025 5:49:35 PM
Am I reading this article correctly (2)
CYDY CytoDyn Inc
07/13/2025 6:13:31 AM
Alzheimer’s Disease - Phase 1 is (2)
CYDY CytoDyn Inc
05/14/2025 6:35:53 AM
Presentation should end 6:45am NY t (1)
CYDY CytoDyn Inc
05/14/2025 6:17:16 AM
12:00 pm Thursday, in Munich, Ger (2)
CYDY CytoDyn Inc
05/14/2025 6:13:51 AM
Presentation isn’t today it’s t (3)
CYDY CytoDyn Inc
01/30/2025 4:34:34 PM
It’s annoying when we have more B (4)
CYDY CytoDyn Inc
11/09/2024 5:40:12 AM
I can”t recall seeing this articl (3)
CYDY CytoDyn Inc
10/09/2024 7:04:36 AM
Good article……Inflammation ever (6)
CYDY CytoDyn Inc
07/28/2024 8:18:50 PM
The European Medicines Agency (EMA) (4)
CYDY CytoDyn Inc
01/29/2024 12:00:05 AM
At least the Chinese are trying to
CYDY CytoDyn Inc
01/04/2024 9:22:23 PM
As far as I understand Leronlimab d (3)
CYDY CytoDyn Inc
12/17/2023 1:08:51 AM
Short Volume Ratio 55.83%. 12/15/23 (4)
CYDY CytoDyn Inc
12/17/2023 1:03:13 AM
USSJ you may find some info on this (1)
CYDY CytoDyn Inc
12/15/2023 6:28:22 PM
Quote from CC “ I'm pleased to an (3)
CYDY CytoDyn Inc
12/14/2023 7:04:33 PM
Did you Faint from the news? :-) (2)
CYDY CytoDyn Inc
08/30/2023 5:37:42 PM
Actually postponed….. “ CytoDyn (8)
CYDY CytoDyn Inc
07/29/2023 8:15:09 AM
Gilead paid $5b for a failed drug s (3)
CYDY CytoDyn Inc
07/14/2023 4:35:34 AM
I’m confused with the FDA hold in (4)
CYDY CytoDyn Inc
07/01/2023 5:25:18 AM
And the link to covid with CCR5 Cov (4)
CYDY CytoDyn Inc
05/19/2023 3:39:11 AM
Doesn’t Cytodyn have to receive F (1)
CYDY CytoDyn Inc
01/15/2023 6:46:15 AM
China records 60,000 Covid deaths i
CYDY CytoDyn Inc
12/20/2022 6:15:16 PM
Madrigal Pharma….. “ The compan (2)
CYDY CytoDyn Inc
12/11/2022 6:10:35 AM
My take on things past, present an (2)
CYDY CytoDyn Inc
11/16/2022 5:25:36 AM
Not sure if we can see these codes
CYDY CytoDyn Inc
09/29/2022 7:22:27 AM
Since we’ve already run a success
CYDY CytoDyn Inc
09/06/2022 9:31:39 AM
A few weeks old but a good read New
CYDY CytoDyn Inc
08/27/2022 11:21:45 PM
Once the first NASH therapeutic is
CYDY CytoDyn Inc
07/03/2022 6:56:10 AM
My understanding is that latent HIV (5)
CYDY CytoDyn Inc
06/30/2022 3:19:43 AM
Maybe they took notice of Novavax a (4)
CYDY CytoDyn Inc
06/29/2022 3:11:25 AM
Since Philippines has shut us out b (6)
CYDY CytoDyn Inc
06/26/2022 6:59:43 AM
Still some unanswered questions on (7)
CYDY CytoDyn Inc
03/11/2022 2:49:55 AM
Covid Long Haulers new case report
CYDY CytoDyn Inc
01/10/2022 2:16:42 AM
May we should consider suing the FD (1)
CYDY CytoDyn Inc
01/09/2022 4:41:41 PM
Maybe we could have a bit of fun an (4)
CYDY CytoDyn Inc
01/08/2022 8:12:39 PM
I agree Goosebumps and thats why I (4)
CYDY CytoDyn Inc
01/07/2022 4:33:41 PM
Hi MarcS, That’s what I heard too (1)
CYDY CytoDyn Inc
12/24/2021 11:49:36 PM
Wishing all Longs a Very Merry and (5)
CYDY CytoDyn Inc
12/23/2021 5:35:16 AM
Good article……. “ Disruption (5)
CYDY CytoDyn Inc
12/18/2021 6:31:44 AM
At least EU isn’t just following (5)
CYDY CytoDyn Inc
12/12/2021 8:17:47 PM
Cytodyn can also request a suspensi (4)
CYDY CytoDyn Inc
12/11/2021 10:52:02 PM
You maybe correct. SK has stated a (4)
CYDY CytoDyn Inc
12/09/2021 6:10:38 AM
Can mods please remind posters of w
CYDY CytoDyn Inc
11/08/2021 6:21:51 AM
This PR is of good quality compared (2)
CYDY CytoDyn Inc
11/08/2021 6:01:13 AM
CytoDyn Submits Breakthrough Therap (6)
CYDY CytoDyn Inc
10/08/2021 9:17:50 PM
Perhaps Management should offer LL
CYDY CytoDyn Inc
09/29/2021 8:18:21 AM
I love this part….. “Regarding (6)
CYDY CytoDyn Inc
09/17/2021 7:02:41 PM
Sorry, damn spell checker…..not u
CYDY CytoDyn Inc
09/17/2021 6:54:23 PM
CRISPR and ZFN can also be used to (3)
CYDY CytoDyn Inc
09/17/2021 6:44:21 PM
CRISPR and Sangamo’s ZFN both hav (3)
CYDY CytoDyn Inc
09/05/2021 6:30:44 PM
I don’t think a normal human bein (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • AMDA College Shines in Playbill's 2024-2025 Broadway Rankings
  • Haivision's Quarterly Financial Report Diverges Amid Growth
  • Vaxart Highlights New Findings on Norovirus Vaccine Efficacy
  • How a $1000 Investment in KLA Could Grow Over 15 Years
  • Important Notice for Fiserv, Inc. Investors Facing Losses
  • Texas Hemp Council Advocates for Minors' Protection in Hemp Biz
  • XingImaging and SynuSight Achieve Milestone in Parkinson’s Research
  • Waystar Launches Exciting Secondary Offering for Investors
  • Cohen & Steers Infrastructure Fund Announces October Distribution
  • Paradox Public Relations Strengthens Global Defense Partnerships
  • Interparfums, Inc. Welcomes New Board Members at Annual Gathering
  • Broadwind's Strategic Motion: Industrial Sale and Outlook
  • Global Ship Lease Announces Exciting Dividend on Preferred Shares
  • Talon Capital Corp. Successfully Completes IPO Raising $249 Million
  • Monroe Capital Corporation Declares $0.25 Dividend for Q3
  • Interlune: Pioneering Lunar Helium-3 Resource Development
  • Investing in Green Housing: A Sustainable Future for All
  • Nano Dimension's Upcoming Financial Results Conference Overview
  • New Affordable Housing Initiative for Seniors Benefits Community
  • Partners Value Investments Inc. Initiates Share Repurchase Plan
  • Ford Motor Company Unveils New Ad Campaign Focused on Lifestyle
  • Crinetics Pharmaceuticals Unveils New Employment Inducements
  • The Transformational Growth of REV Group Investments Revealed
  • Monroe Capital Corporation Announces Quarterly Distribution Update
  • Robin Energy Pursues Public Stock Offering for Growth Plans
  • Alliance Entertainment's Remarkable Growth in Fiscal Year 2025
  • Aviat Networks Posts Impressive Growth for Fiscal 2025 Results
  • Oxford Industries Reports Solid Q2 Results Amid Challenges
  • Kewaunee Scientific Q1 FY2026 Performance Highlights and Insights
  • Lesaka Technologies Reports Significant Growth in FY2025
  • Oxford Industries Sees Stock Surge Following Strong Earnings
  • Kewaunee Scientific's First Quarter Success Highlights
  • Cohen & Steers Infrastructure Fund Announces Rights Offering Details
  • Citius Oncology Secures $9 Million for Innovative Cancer Solutions
  • Health In Tech Set to Host Virtual Stockholder Meeting Soon
  • Condado Tacos Unveils Exciting Fall Menu Full of Protein
  • Aberdeen Income Credit Strategies Fund Announces Dividend Payout
  • Aberdeen Investments U.S. Funds Announce Updated Distribution Details
  • Insights on Monthly Distribution of abrdn Asia-Pacific Fund
  • Englobe Expands Canadian Presence with LRL Acquisition
  • Brixmor Property Group Unveils Q3 2025 Earnings Call Details
  • Evaluating Clean Harbors: A Look at Market Sentiment and Trends
  • Recent Trends in Starwood Property Trust's Market Activity
  • Analyzing the Market Dynamics of MidCap Financial (MFIC)
  • The Remarkable Growth of Moody's Investment Potential
  • Royal Caribbean Group Announced Significant Dividend Increase
  • Advancements in Plantar Fibromatosis Treatments by Endo
  • M-tron Industries' Focus on Expansion at Upcoming Conference
  • Farmer Mac Announces Dividend for Series H Preferred Stock
  • Lesaka Technologies Posts Encouraging FY2025 Results Ahead
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site